Combination treatment in metastatic prostate cancer: is the bar too high or have we fallen short?

Nature Reviews Urology, Published online: 12 December 2022; doi:10.1038/s41585-022-00669-zCombination treatment with androgen deprivation therapy plus chemotherapy or novel hormonal agents showed promising results for the treatment of patients with newly diagnosed metastatic prostate cancer. However, real-world data show a very low uptake of this therapy in clinical practice. In this Perspective, the authors discuss data and potential reasons behind this trend.

Source: Nature Reviews Urology - December 12, 2022 Category: Urology & Nephrology Authors: Kenneth Chen Jonathan O ’Brien Aoife McVey Pocharapong Jenjitranant Brian D. Kelly Veeru Kasivisvanathan Nathan Lawrentschuk Declan G. Murphy Arun A. Azad Source Type: research